Metabolic responses and benefits of glucagon‐like peptide‐1 (GLP‐1) receptor ligands

Glucagon‐like peptide‐1 (GLP‐1) is an incretin hormone that has undergone a revolutionary turnaround from discovery to clinically approved therapeutic. Rapid progress in drug design and formulation has led from initial development of short‐ and long‐acting drugs suitable for daily or weekly parenter...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanday, Neil, Flatt, Peter R., Irwin, Nigel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
GLP1 RECEPTOR LIGANDS (BJP 75th ANNIVERSARY) ‐ THEMED ISSUE REVIEWS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820187/
https://www.ncbi.nlm.nih.gov/pubmed/33822370
http://dx.doi.org/10.1111/bph.15485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820187/
https://www.ncbi.nlm.nih.gov/pubmed/33822370
http://dx.doi.org/10.1111/bph.15485

Ejemplares similares